Fresh Tracks Therapeutics, Inc. Profile Avatar - Palmy Investing

Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company dev…

Biotechnology
US, Boulder [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
Fresh Tracks Therapeutics, Inc. can't present any analysts estimates at the moment detail analysis.
Intraday
Shares Outstanding
5,973,310
Volume
196
Volume on Avg.
2,109
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $0.66 per share Last Form/Filing Last Transaction
10% Holder
Exploration Capital, Llc
Uncategorized SEC Entity
1,739,412 $1,148,011.92
06/11/24
Officers/Directors Below 10%
Fox-Collis Aaron
Internal : VP of Finance & CAO
0 $0
12/11/23
S
74 x $0.91 = $67.34
Marchio Albert N Ii
Internal : CEO and CFO
0 $0
05/09/22
0 x $0 = $0
Chadha Deepak
Internal : Former Chief R&D Officer & COO
0 $0
05/09/22
0 x $0 = $0
Sklawer Andrew D
Internal : President and CEO
0 $0
05/09/22
0 x $0 = $0
Mcavoy David R.
Internal : Gen Counsel, CCO, & Secretary
128,879 $85,060.14
07/27/21
P
18,124 x $0.67 = $12,143.08
Hardy Reginald L
Internal : CHAIRMAN OF THE BOARD
448,411 $295,951.26
07/27/21
P
100,000 x $0.67 = $67,000.00
Samant Vijay B
Internal : Director
0 $0
05/17/22
0 x $0 = $0
Lyons Gary A
Internal : Director
0 $0
05/17/22
0 x $0 = $0
Veru Dennison T
Internal : Director
0 $0
06/14/21
0 x $0 = $0
Breton Jose
Internal : Chief Accounting Officer
0 $0
05/09/22
0 x $0 = $0
Luchi Monica E.
Internal : Chief Medical Officer
0 $0
09/03/21
0 x $0 = $0
Brown Robert Busard
Internal : Chief Executive Officer
0 $0
05/09/22
0 x $0 = $0
End of FRTX's Analysis
CIK: 819050 CUSIP: - ISIN: US10802T2042 LEI: - UEI: -
Secondary Listings
FRTX has no secondary listings inside our databases.